Quick Summary
Jasbuzz Tablet
Last updated on 19 May 2026 | 05:44 AM (IST)
₹1435
MRP: ₹4100
(You Save ₹2665)
30 TABLET(s) IN A BOTTLE
Jasbuzz Tablet
Salt Composition
BICTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDEMarketer
JASGUR LIFE SCIENCES LLP
65% OFF
₹1435
MRP: ₹4,100.00
Inclusive of all taxes
65% Off
Salt Composition
BICTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDEMarketer
JASGUR LIFE SCIENCES LLP
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
3 Mune Tablet
CIPLA LTD
₹ 69.60/tablet
46% costlier
Alcibicla Tablet
MYLAN PHARMACEU...
₹ 73.33/tablet
54% costlier
Lagmitaf Tablet
LAURUS LABS LTD
₹ 93.73/tablet
96% costlier
Taftrio Tablet
HETERO HEALTHCA...
₹ 97.50/tablet
104% costlier
Introduction
Jasbuzz Tablet is an antiretroviral drug that contains Bictegravir, Emtricitabine, and Tenofovir Alafenamide. It is used in the treatment of HIV-1 infection. It is a Human immunodeficiency virus that primarily attacks and weakens a person's immune system (HIV). This infection progressively weakens the immune system, making individuals more susceptible to opportunistic infections.
Do not take this drug if allergic to Jasbuzz Tablet and other ingredients. During the early stages of HIV-1 treatment, some patients may experience an inflammatory response to opportunistic infections. This condition is called immune reconstitution syndrome. It can occur after starting the drug or other antiretroviral therapies. Knowing this possibility and monitoring for any signs of worsening infections or inflammatory symptoms is necessary. Report to your doctor if you have had a history of heart failure, pancreatitis, bone disease, fractures, liver or kidney problems. Patients diagnosed with pancreatitis or at risk of pancreatitis should take this combination of medicine cautiously. During the treatment, your doctor may periodically monitor your blood counts, bone mineral density, and liver and kidney parameters to prevent serious complications.
Adults of childbearing potential should consider using an effective contraceptive to prevent an unwanted pregnancy. If you are pregnant or think you might be pregnant, your physician might suggest an alternative treatment, as this combination regimen is not recommended during early pregnancy. Breastfeeding is not recommended due to the possible transmission of HIV-1 infection from the mother to the baby. It's necessary to inform your doctor about all your medications, including prescription, over-the-counter, and herbal supplements, to ensure no potential interactions. Jasbuzz tablet Price in India. Buy Jasbuzz tablet online in MrMed.
Uses
Jasbuzz tablet uses
Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection
How Jasbuzz Tablet Works
Jasbuzz Tablet combines integrase strand transfer inhibitors and nucleoside, nucleotide analogue reverse transcriptase inhibitors. It increases the number of CD4 T cells and stimulates the immune system to fight against infections. Thereby, it reduces the viral load of HIV in the blood and decreases the severity of HIV infection.
Interaction of Jasbuzz Tablet with other drugs
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Jasbuzz Tablet and can cause undesirable side effects.
Storage Conditions
Store Jasbuzz Tablet at room temperature below 30°C.
Keep out of sight and reach of pets and children.
How to consume Jasbuzz Tablet
Take the Jasbuzz Tablet as advised by your physician. Swallow the tablets whole and intact. This tablet should be taken with food. Do not crush, chew, or open the jasbuzz medicine. Your physician will decide the correct Jasbuzz tablet dosage and duration based on age, body weight, and disease condition. Only stop taking the medicine if your doctor advises you to stop.
Safety Advices
Pregnancy
Breastfeeding is not recommended in individuals taking a Jasbuzz Tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Alcohol
It is unsafe to consume alcohol while taking a Jasbuzz Tablet. It may reduce the drug's effectiveness and can cause toxic side effects.
Liver
Jasbuzz Tablets should be cautiously administered in patients with severe liver diseases. Dose adjustments are necessary for severe liver failure. Inform your doctor if you have liver problems before initiating the therapy.
Lungs
Whether Jasbuzz Tablet is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Driving
Jasbuzz Tablets can make you feel dizzy and affect your concentration. Do not drive or operate machinery.
Pregnancy
Consult your physician if you are pregnant or planning for pregnancy during the treatment with Jasbuzz Tablet.
Side Effects
Jasbuzz tablet side Effects are unwanted symptoms caused by medicines. Although all medicines cause side effects, not everyone gets them.
Serious
Bone loss
Worsening of Hepatitis B
Kidney injury
Immune reconstitution syndrome
Lactic acidosis
Liver toxicity
Common
Depression
Abnormal dreams
Headache
Dizziness
Diarrhea
Feeling sick (Nausea)
Tiredness (Fatigue)
Expert Tips
To prevent the spread of HIV-1 infection, avoid sharing needles or syringes, which can transmit HIV-1 infections easily. It's necessary for individuals who use injectable drugs to use sterile needles and syringes and never share them with others. Personal items like toothbrushes, razor blades, or anything with body fluids or blood should also be avoided. They should not be shared because HIV-1 can be present in blood and certain body fluids, and sharing these items could mainly transmit the virus. Do not have any sex without protection. It is necessary to practice safe sex using a polyurethane condom or latex to lower the risk of sexual contact with semen, vaginal secretions, or blood.
If you remember to take a Jasbuzz Tablet for the entire day, take your usual dose the next day. However, do not double-dose yourself. Do not store this tablet in a moist place like a bathroom cabinet or near the kitchen sink. Keep your tablet in a tightly closed container. Do not accept if the seal over the bottle opening is broken or missing. This medicine was prescribed for your specific condition. Please do not use it for other conditions. Do not give this tablet to others, even if they have the same symptoms like you have. It may harm them.
Frequently Asked Questions(FAQs)
Q1.
What should you not take with a Jasbuzz Tablet?
Taking Jasbuzz Tablet with antacids is not recommended. Tell your healthcare provider about taking other medications, over-the-counter drugs, vitamins, or herbal supplements
Q2.
What Should I Do If I Have Difficulty Swallowing a Jasbuzz Tablet?
If you have problems swallowing Jasbuzz Tablet, split the tablet into two and take them separately within 10 minutes.
Q3.
What is the Proper Storage Method for Jasbuzz Tablet?
Store Jasbuzz Tablet at room temperature in a tightly closed container away from the reach of children.
Q4.
What are the required laboratory parameters before starting this treatment with Jasbuzz Tablet?
If you are an adolescent or adult of childbearing potential, your healthcare provider will perform a pregnancy test before prescribing Jasbuzz Tablet. Other prominent tests for HBV infection are serum creatinine, estimated creatinine clearance, urine glucose, and urine protein.
Q5.
What should you do if you miss a dose of Jasbuzz Tablet?
If you missed a dose of Jasbuzz Tablet, take one tablet when you remember. Anyhow, if it is almost time for your next dose, skip this dose and take your next dose as per schedule. Do not double the dose to compensate for the missed dose.
Q6.
What are some of the long-term side effects of the Jasbuzz Tablet combination regimen?
Some serious side effects of Jasbuzz Tablet combination regimen include worsening hepatitis B, bone loss, kidney injury, pancreatitis, immune reconstitution syndrome, liver toxicity, and hypersensitivity reactions.
Fact Box
Molecule name: Bictegravir, Emtricitabine, Tenofovir Alafenamide | Therapeutic class: Antiretroviral |
Pharmacological class: 1. Bictegravir-Integrase strand transfer inhibitor (INSTI) 2.Emtricitabine-Nucleoside reverse transcriptase inhibitor (NRTI) 3.Tenofovir Alafenamide-Nucleotide reverse transcriptase inhibitor (NtRTI) | Indication: Treatment of human immunodeficiency virus 1 (HIV-1) infection |
References
Gilead Sciences Inc., U.S. Food and Drug Administration (EMC), [Revised on Oct 2021] [Accessed on 20th May 2023], https://www.medicines.org.uk/emc/files/pil.9313.pdf
KD Tripathi, Antiviral Drugs (Anti-retrovirus), Essentials of Medical Pharmacology, 8th Edition, 2019, 860-872.
Goodman & Gilman's, The Pharmacological Basis of Therapeutics, Antiretroviral agents and treatment of HIV infection, 12th Edition, 2011, 1634-1638.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
P. Thirumal Reddy
B. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 19 May 2026 | 05:44 AM (IST)
Want to know more?
Read Our Editorial Policy